Coronavirus 2019-2020 thread (no unsubstantiated rumours!)
- Thread starter localizer
- Start date
Jura The idiot
General
Intrepid
Major
Germany has 20,000 intensive care beds reported, of which 12,000 are currently occupied. Among them are 2500 Covid-19 patients, predictable treatments for other diseases had to be postponed. The number of seriously ill Covid-19 patients will increase in the next 14 days. But the authorities have calculated that the free intensive care beds will be enough ().
The number of available intensive care beds determines how strong the measures have to be and how much freedom can remain for a functioning economy.
Because every change takes effect in 14 days and has to be predicted, the government's voting process is very intense and emotional. In fact, there are 17 governments: the federal government and 16 state governments. Not an easy job!
The number of active cases is decreasing in Austria, Germany and Switzerland.
AssassinsMace
Lieutenant General
That's not uncommon for general news in the US. A lot of small TV stations buy news scripts and video footage so these stations don't have to pay writers. It's like when you buy local newspapers, most of the stories are AP, Reuters, New York Times, and the Washington Post. Local content is minimal.
superdog
Junior Member
Dying and antibody count will not be the only thing they measure. I'm sure they will keep a keen eye on any adverse effects and changes to physiology, for which you cannot confidently attribute to the vaccine if you don't keep a placebo control group to compare with.
I don't think any ethics committee will (or should) approve a test that will actively infect someone with COVID-19.
Without going to lengthy discussion. The main takeaway from this paper is "we found that haplotypes H13 and H38 might be considered as ancestral haplotypes, and later H1 (whose descendants included all samples from the Huanan Seafood Wholesale Market) was
derived from the intermediate haplotype H3." and "Neither H13 nor H38 has samples from Wuhan (Hubei) " . While these haplotypes may exist outside of Wuhan, inside China, It does not mean it ONLY exist in China as the data set used was as I said China centric. Hence, the research is only valid for the data set used, which is by no means comprehensive.
Also, Please read the paper again, They did not suggest that the H1 haplotypes made the initial jump to human. Instead they are saying that the virus likely mutated to H1 haplotypes after initial jump to human. I hope you see the difference.
The likely scenario they presented was that the initial jump to human was either haplotypes H13 and H38 or an intermediary H3.
Also, they discounted that the Wuhan wet market as source of the virus, It does not mean that it did not occur in other wet markets in China. But at same time, there was no inference that the origin was a wet market. Neither was there any conclusion the initial jump was in China. They are only able to trace it within China as their data set is again very China centric. Hence, any inference that the origin of COVID-19 was from a wet market or in China is scientifically premature.
To scientifically determine the origin, one have to trace the H13, H38 or H3 haplotypes find where initial jump to human occured. That's all.
Intrepid
Major
I forgot to write: The hospitals in Germany are paid by the state for the intensive care beds that are kept free as a precaution for future expected Covid 19 patients.
manqiangrexue
Brigadier
All those things are to be carefully monitored in the test groups to see how they are affected by the vaccine; I understand that. I was saying that there's basically nothing be be gained from a control group, which is basically injected with just the saline that the vaccine is suspended in. Scientifically speaking, strictly, you need a control group to make sure there was nothing wrong with your medium and that the therapeutic effects seen aren't due to placebo effect but in this case, there's really no reason as no placebo effect in the world can create specific antibodies.
Why not? Young and healthy people have nearly zero chance of mortality, especially if religiously monitored and provided top tier care. If you don't run the test through to show that the vaccine actually defends against COVID-19 challenge, you risk administering a vaccine that doesn't work to millions of people. If you run phase 3, it takes an incredibly long time and people are dying. On the other hand, if you do a COVID-19 challenge on a smaller (but still statistically significant) group, you speed things along dramatically. Labs are considering it and people are willing; check it out:
Last edited:
That too.
Dogs adaptable.
And what about Tibetan Mastiffs? Used to go for thousands of USD.
and then being sold $5 per head for the pot.
I would say, it actually makes sense to deliberately infect (some) with the average dose of the vaccine.
You'll get some preliminary results on effectiveness, which means it could be used for medical personnel during the Autumn infection wave which is likely.